Brad Friedman Share Ph.D., Senior Principal Scientist, Department of OMNI Bioinformatics, Genentech, Inc
A Cancer Drug for ALS? Organization Forges Promising ALS Treatment, an Innovative Approach to Incubate Novel Therapeutics